Tetraphase announces determination of superior offer and notice to acelrx

Tetraphase pharmaceuticals, inc. (nasdaq:ttph), a biopharmaceutical company focused on commercializing its novel tetracycline xerava™ (eravacycline fo

CVI Ratings Summary

CVI Quant Ranking